NEEDHAM, Mass.--(BUSINESS WIRE)--
Celldex
Therapeutics, Inc. (NASDAQ: CLDX) announced today that Anthony
Marucci, President and Chief Executive Officer, is scheduled to present
a corporate overview at the Oppenheimer 23rd Annual Healthcare
Conference on Wednesday, December 12, 2012 at 10:00 am ET at the
Waldorf=Astoria in New York City.
A live
webcast of the presentation will be available online on the "Events
& Presentations" page of the "Investors & Media" section of the Celldex
website. A replay of the presentation will be available for 30 days
following the event.
About Celldex Therapeutics, Inc.
Celldex Therapeutics is the first antibody-based combination
immunotherapy company. Celldex has a pipeline of drug candidates in
development for the treatment of cancer and other difficult-to-treat
diseases based on its antibody focused Precision Targeted Immunotherapy
(PTI) Platform. The PTI Platform is a complementary portfolio of
monoclonal antibodies, antibody-targeted vaccines and immunomodulators
used in optimal combinations to create novel disease-specific drug
candidates. For more information, please visit www.celldextherapeutics.com.
Celldex Therapeutics, Inc.
Sarah Cavanaugh, 781-433-3161
Vice
President of IR & Corp Comm
scavanaugh@celldextherapeutics.com
or
For
Media:
BMC Communications
Brad Miles, 646-513-3125
bmiles@bmccommunications.com
Source: Celldex Therapeutics, Inc.
News Provided by Acquire Media
